Backed by science.
Created by scientists

Auria is intended for women ages 30 and over. Auria is for all bodies & all breasts: dense breasts, implants, screening avoidant, or lack of access. For more information on whether you are a good candidate for Auria, visit our About Auria page.

Auria is not intended for women with an unevaluated palpable mass or area of concern in their breast tissue. It is also not intended for women who no longer have breast tissue.

Clinical data is not yet available for patients who are currently being treated for breast cancer, have been recently diagnosed with cancer, or are being monitored for reoccurrence.

Current data only supports biological females at birth with breast tissue. Upcoming clinical trials with our LGBTQIA+ community and biological males at birth is underway to expand Auria’s availability.

Auria has a sensitivity of 92% which means out of 100 women with breast cancer, Auria would classify 92 of those women as clinically significant (or above the diagnostic threshold); the remaining 8 are identified as negative.

Auria has a specificity of 58%, which means out of 100 normal women, Auria would classify 58 of them as negative.

We have preferentially selected our algorithm to have a higher sensitivity in order to reduce the number of missed cancers (i.e. false negatives). As with all lab-developed tests, continued use of our assay will allow for optimization of the diagnostic parameters.

Auria uses innovative proteomic science to give real-time results to aid in early detection. Auria measure levels of 2 protein biomarkers in your tears that may be associated with an abnormality in the breast tissue or breast cancer.

Auria is designed to supplement routine screening and not replace it. Auria is for information and educational use only. It is not intended to be used for diagnostic purposes. If you feel a lump or have an area of concern, please see your health care provider.

Auria looks for the proteins S100A8 and S100A9 as homodimers. These proteins can be found in two different forms with different functions:

1 - Independent of one another, as homodimers.

2 - As part of a protein complex, calprotectin, that is created when S100A8 and S100A9 join as a pair, called a heterodimer.

Auria’s test measures S100A8 and S100A9 separately as homodimers and DOES NOT measure the calprotectin heterodimer.

You can read more information about the science behind Auria at https://namidalab.com/news/category/publication